Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion description "[Atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDL) and dedifferentiated liposarcoma (DDL) are reported to have murine double-minute type 2 (MDM2) and cyclin-dependent kinase 4 (CDK4) amplification as a characteristic genetic alteration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion evidence source_evidence_literature NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion SIO_000772 16938516 NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion wasDerivedFrom befree-20150227 NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_assertion wasGeneratedBy ECO_0000203 NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.
- befree-20150227 importedOn "2015-02-27" NP301616.RAW_A56DZ-5TsUV0iQ2MKpIQKm3g5lVlpfm7VdFSFnplU130_provenance.